• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

欧洲丙型肝炎病毒1b型分离株NS5A蛋白的序列分析及其与干扰素敏感性的关系。

Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.

作者信息

Duverlie G, Khorsi H, Castelain S, Jaillon O, Izopet J, Lunel F, Eb F, Penin F, Wychowski C

机构信息

Virologie, CHU-Hôpital Sud, Amiens, France.

出版信息

J Gen Virol. 1998 Jun;79 ( Pt 6):1373-81. doi: 10.1099/0022-1317-79-6-1373.

DOI:10.1099/0022-1317-79-6-1373
PMID:9634077
Abstract

Japanese studies have defined the discrete 2209-2248 amino acid region of the non-structural 5A protein (NS5A(2209-2248)) of hepatitis C virus genotype 1b (HCV 1b) isolates as the interferon sensitivity determining region (ISDR). European studies did not confirm these results since most of the ISDR sequences harboured an intermediate profile. Recently, a direct interaction between the NS5A protein, involving the ISDR, and the interferon-induced protein kinase (PKR) has been reported and presented as a possible explanation of HCV interferon resistance. In the present study, the entire NS5A amino acid sequence from 11 resistant and eight sensitive strains from European HCV 1b isolates was inferred from direct sequencing. The previously described important amino acid stretches and positions in NS5A were compared between the resistant and sensitive groups. Although some variations were observed, no clear differences could be directly correlated with the interferon sensitivity. However, sensitive strains were different, owing to more amino acid changes when compared to a consensus sequence from all strains. The carboxy-terminal region and especially the previously reported NS5A/V3 region showed most of the variations. Moreover, the conformational analysis of NS5A by secondary structure prediction allowed the differentiation of most sensitive strains from resistant ones. It was concluded that other regions different from ISDR were involved in resistance to interferon maybe via the interaction between NS5A and PKR.

摘要

日本的研究已将丙型肝炎病毒1b型(HCV 1b)分离株非结构5A蛋白(NS5A(2209 - 2248))中2209 - 2248个氨基酸的离散区域定义为干扰素敏感性决定区域(ISDR)。欧洲的研究并未证实这些结果,因为大多数ISDR序列呈现出中间特征。最近,有报道称NS5A蛋白(涉及ISDR)与干扰素诱导蛋白激酶(PKR)之间存在直接相互作用,并将此作为HCV对干扰素耐药的一种可能解释。在本研究中,通过直接测序推断出欧洲HCV 1b分离株中11株耐药株和8株敏感株的整个NS5A氨基酸序列。比较了耐药组和敏感组之间NS5A中先前描述的重要氨基酸片段和位置。尽管观察到了一些差异,但没有明确的差异能直接与干扰素敏感性相关。然而,敏感株有所不同,因为与所有菌株的共有序列相比,其氨基酸变化更多。羧基末端区域,尤其是先前报道的NS5A/V3区域显示出大部分变异。此外,通过二级结构预测对NS5A进行构象分析,能够区分大多数敏感株和耐药株。得出的结论是,不同于ISDR的其他区域可能通过NS5A与PKR之间的相互作用参与了对干扰素的耐药。

相似文献

1
Sequence analysis of the NS5A protein of European hepatitis C virus 1b isolates and relation to interferon sensitivity.欧洲丙型肝炎病毒1b型分离株NS5A蛋白的序列分析及其与干扰素敏感性的关系。
J Gen Virol. 1998 Jun;79 ( Pt 6):1373-81. doi: 10.1099/0022-1317-79-6-1373.
2
Interferon resistance of hepatitis C virus genotype 1b: relationship to nonstructural 5A gene quasispecies mutations.丙型肝炎病毒1b基因型的干扰素耐药性:与非结构5A基因准种突变的关系。
J Virol. 1998 Apr;72(4):2795-805. doi: 10.1128/JVI.72.4.2795-2805.1998.
3
NS5A(ISDR-V3) region genetic variability of Tunisian HCV-1b strains: Correlation with the response to the combined interferon/ribavirin therapy.NS5A(ISDR-V3) 区域遗传变异性与突尼斯 HCV-1b 株对联合干扰素/利巴韦林治疗反应的相关性。
J Med Virol. 2009 Dec;81(12):2021-8. doi: 10.1002/jmv.21641.
4
Is investigation of hepatitis C virus NS5A gene heterogeneity a tool for predicting long-lasting response to interferon therapy in patients with HCV-1b chronic hepatitis?丙型肝炎病毒NS5A基因异质性的研究是否是预测HCV-1b型慢性肝炎患者对干扰素治疗长期反应的一种工具?
J Viral Hepat. 2002 Sep;9(5):360-9. doi: 10.1046/j.1365-2893.2002.00379.x.
5
Control of PKR protein kinase by hepatitis C virus nonstructural 5A protein: molecular mechanisms of kinase regulation.丙型肝炎病毒非结构5A蛋白对PKR蛋白激酶的调控:激酶调节的分子机制
Mol Cell Biol. 1998 Sep;18(9):5208-18. doi: 10.1128/MCB.18.9.5208.
6
Prospective characterization of full-length hepatitis C virus NS5A quasispecies during induction and combination antiviral therapy.在诱导和联合抗病毒治疗期间对全长丙型肝炎病毒NS5A准种进行前瞻性特征分析。
J Virol. 2000 Oct;74(19):9028-38. doi: 10.1128/jvi.74.19.9028-9038.2000.
7
[Mutation analysis of ISDR and V3 domains of hepatitis C virus NS5A region before interferon therapy with or without ribavirin].[在使用或不使用利巴韦林进行干扰素治疗前对丙型肝炎病毒NS5A区域的ISDR和V3结构域进行突变分析]
Pathol Biol (Paris). 2004 Nov;52(9):505-10. doi: 10.1016/j.patbio.2004.07.011.
8
Mutations in the interferon-sensitivity determining region of hepatitis C virus and transcriptional activity of the nonstructural region 5A protein.丙型肝炎病毒干扰素敏感性决定区的突变与非结构区5A蛋白的转录活性
Hepatology. 1998 Oct;28(4):1147-53. doi: 10.1002/hep.510280433.
9
Mutations in the NS5A gene of hepatitis C virus in North American patients infected with HCV genotype 1a or 1b.感染丙型肝炎病毒1a或1b基因型的北美患者中丙型肝炎病毒NS5A基因的突变
J Med Virol. 1997 Oct;53(2):118-26. doi: 10.1002/(sici)1096-9071(199710)53:2<118::aid-jmv3>3.0.co;2-c.
10
[Construction and sequence analysis of recombinant HCV-1b replicon by replacing NS5A region].
Nan Fang Yi Ke Da Xue Xue Bao. 2012 Jan;32(1):46-9.

引用本文的文献

1
The Relationship Between HCV-NS5A Gene Mutations and Resistance to Combination Therapy in Patients with HCV- Genotype 1-B.丙型肝炎病毒1-B基因型患者中HCV-NS5A基因突变与联合治疗耐药性的关系
Rep Biochem Mol Biol. 2021 Jul;10(2):233-242. doi: 10.52547/rbmb.10.2.233.
2
Frequency of nucleotide sequence variations in the internal ribosome entry site region of hepatitis C virus RNA isolated from responding and non-responding patients with hepatitis C virus genotype 3 infection.从丙型肝炎病毒3型感染的有反应和无反应患者中分离出的丙型肝炎病毒RNA内部核糖体进入位点区域核苷酸序列变异的频率。
Virusdisease. 2016 Sep;27(3):251-259. doi: 10.1007/s13337-016-0335-7. Epub 2016 Aug 6.
3
Natural non-homologous recombination led to the emergence of a duplicated V3-NS5A region in HCV-1b strains associated with hepatocellular carcinoma.
自然非同源重组导致与肝细胞癌相关的丙型肝炎病毒1b型(HCV-1b)毒株中出现了一个重复的V3-NS5A区域。
PLoS One. 2017 Apr 10;12(4):e0174651. doi: 10.1371/journal.pone.0174651. eCollection 2017.
4
Systematic identification of anti-interferon function on hepatitis C virus genome reveals p7 as an immune evasion protein.对丙型肝炎病毒基因组上抗干扰素功能的系统鉴定揭示p7是一种免疫逃避蛋白。
Proc Natl Acad Sci U S A. 2017 Feb 21;114(8):2018-2023. doi: 10.1073/pnas.1614623114. Epub 2017 Feb 3.
5
The role of HCV proteins on treatment outcomes.丙型肝炎病毒(HCV)蛋白对治疗结果的作用。
Virol J. 2015 Dec 15;12:217. doi: 10.1186/s12985-015-0450-x.
6
A novel approach to identify candidate prognostic factors for hepatitis C treatment response integrating clinical and viral genetic data.一种新方法,通过整合临床和病毒遗传数据,鉴定丙型肝炎治疗反应的候选预后因素。
Evol Bioinform Online. 2015 Feb 23;11:15-24. doi: 10.4137/EBO.S20853. eCollection 2015.
7
Impact of hepatitis C virus heterogeneity on interferon sensitivity: an overview.丙型肝炎病毒异质性对干扰素敏感性的影响:综述
World J Gastroenterol. 2014 Jun 28;20(24):7555-69. doi: 10.3748/wjg.v20.i24.7555.
8
On hepatitis C virus evolution: the interaction between virus and host towards treatment outcome.丙型肝炎病毒进化:病毒与宿主之间的相互作用与治疗结局。
PLoS One. 2013 Apr 25;8(4):e62393. doi: 10.1371/journal.pone.0062393. Print 2013.
9
Analysis of HCV quasispecies dynamic under selective pressure of combined therapy.联合治疗选择性压力下 HCV 准种动态分析。
BMC Infect Dis. 2013 Feb 1;13:61. doi: 10.1186/1471-2334-13-61.
10
dsRNA-dependent protein kinase PKR and its role in stress, signaling and HCV infection.双链 RNA 依赖的蛋白激酶 PKR 及其在应激、信号转导和 HCV 感染中的作用。
Viruses. 2012 Oct 29;4(11):2598-635. doi: 10.3390/v4112598.